FDA to weigh easing limits on unproven peptides favored by RFK Jr. and other MAHA figures
The FDA will convene a panel of advisors in July to consider easing restrictions on seven peptide injections. These unapproved therapies are popular among wellness influencers and celebrities, who promote them for muscle building, injury healing, and anti-aging.
Briefing Summary
AI-generatedThe FDA will convene a panel of advisors in July to consider easing restrictions on seven peptide injections. These unapproved therapies are popular among wellness influencers and celebrities, who promote them for muscle building, injury healing, and anti-aging. The meeting follows pledges from Health Secretary Robert F. Kennedy Jr., who has discussed using peptides himself, to loosen regulations. Some supporters of Kennedy's "Make America Healthy Again" movement also promote and sell these peptides. The FDA will review whether the peptides, including BPC-157, should be removed from a restrictive category for risky, customized drugs, despite concerns from former FDA officials about the lack of safety testing.
Article analysis
Model · rule-basedKey claims
5 extractedThere’s little research behind those claims and most peptides have not been reviewed for safety by the FDA.
Peptides are often pitched as a quick way to build muscle, heal injuries or appear younger.
Robert F. Kennedy Jr. has pledged to loosen regulations on peptides.
FDA will hold a meeting to consider easing restrictions on peptide injections.
Allowing peptides on the market without clinical testing poses a “profound threat” to FDA’s vetting system.